INFUSYSTEM HOLDINGS INC (INFU) Stock Price & Overview

NYSEARCA:INFUUS45685K1025

Current stock price

9.7 USD
-0.09 (-0.92%)
At close:
9.7 USD
0 (0%)
After Hours:

The current stock price of INFU is 9.7 USD. Today INFU is down by -0.92%. In the past month the price increased by 5.55%. In the past year, price increased by 77.33%.

INFU Key Statistics

52-Week Range4.61 - 11.04
Current INFU stock price positioned within its 52-week range.
1-Month Range7.29 - 10.065
Current INFU stock price positioned within its 1-month range.
Market Cap
196.134M
P/E
30.31
Fwd P/E
22.87
EPS (TTM)
0.32
Dividend Yield
N/A

INFU Stock Performance

Today
-0.92%
1 Week
+1.57%
1 Month
+5.55%
3 Months
+8.26%
Longer-term
6 Months -6.19%
1 Year +77.33%
2 Years +13.19%
3 Years +25.16%
5 Years -52.36%
10 Years +175.57%

INFU Stock Chart

INFUSYSTEM HOLDINGS INC / INFU Daily stock chart

INFU Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to INFU. When comparing the yearly performance of all stocks, INFU is one of the better performing stocks in the market, outperforming 90.84% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

INFU Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to INFU. INFU has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

INFU Earnings

On February 24, 2026 INFU reported an EPS of 0.1 and a revenue of 36.23M. The company beat EPS expectations (35.41% surprise) and missed revenue expectations (-3.16% surprise).

Next Earnings DateMay 6, 2026
Last Earnings DateFeb 24, 2026
PeriodQ4 / 2025
EPS Reported$0.10
Revenue Reported36.23M
EPS Surprise 35.41%
Revenue Surprise -3.16%

INFU Forecast & Estimates

11 analysts have analysed INFU and the average price target is 14.48 USD. This implies a price increase of 49.32% is expected in the next year compared to the current price of 9.7.

For the next year, analysts expect an EPS growth of 32.54% and a revenue growth 0.56% for INFU


Analysts
Analysts83.64
Price Target14.48 (49.28%)
EPS Next Y32.54%
Revenue Next Year0.56%

INFU Groups

Sector & Classification

INFU Financial Highlights

Over the last trailing twelve months INFU reported a non-GAAP Earnings per Share(EPS) of 0.32. The EPS increased by 220% compared to the year before.


Income Statements
Revenue(TTM)143.44M
Net Income(TTM)6.63M
Industry RankSector Rank
PM (TTM) 4.62%
ROA 6.59%
ROE 11.56%
Debt/Equity 0.34
Chartmill High Growth Momentum
EPS Q2Q%150%
Sales Q2Q%7.04%
EPS 1Y (TTM)220%
Revenue 1Y (TTM)6.36%

INFU Ownership

Ownership
Inst Owners81.22%
Shares20.22M
Float18.78M
Ins Owners4.83%
Short Float %0.59%
Short Ratio0.8

About INFU

Company Profile

INFU logo image InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 461 full-time employees. The company went IPO on 2006-06-15. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.

Company Info

IPO: 2006-06-15

INFUSYSTEM HOLDINGS INC

3851 West Hamlin Road

Rochester Hills MICHIGAN 48309 US

CEO: Richard DiIorio

Employees: 461

INFU Company Website

INFU Investor Relations

Phone: 12482911210

INFUSYSTEM HOLDINGS INC / INFU FAQ

Can you describe the business of INFUSYSTEM HOLDINGS INC?

InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 461 full-time employees. The company went IPO on 2006-06-15. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.


What is the current price of INFU stock?

The current stock price of INFU is 9.7 USD. The price decreased by -0.92% in the last trading session.


Does INFU stock pay dividends?

INFU does not pay a dividend.


How is the ChartMill rating for INFUSYSTEM HOLDINGS INC?

INFU has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


Where is INFUSYSTEM HOLDINGS INC (INFU) stock traded?

INFU stock is listed on the NYSE Arca exchange.


Can you provide the PE ratio for INFU stock?

The PE ratio for INFUSYSTEM HOLDINGS INC (INFU) is 30.31. This is based on the reported non-GAAP earnings per share of 0.32 and the current share price of 9.7 USD.


What is INFUSYSTEM HOLDINGS INC worth?

INFUSYSTEM HOLDINGS INC (INFU) has a market capitalization of 196.13M USD. This makes INFU a Micro Cap stock.